To access this element change to forms mode OFF

Grant Award View - GA278326

Splice switching oligonucleotides for the treatment of chronic kidney...

Contact Details

NHMRC Research Help Centre

:
1800500393

:

GA ID:
GA278326
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
7-Dec-2022
Publish Date:
9-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$998,513.10 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Splice switching oligonucleotides for the treatment of chronic kidney disease
Purpose:
RNA can now be used to safely and selectively treat human diseases.

RNA can be used as a template to make a new protein, such as in mRNA vaccines.

But RNA can also be used change how coding elements are spliced together and the protein that results from them.

This strategy has recently been used to great effect in difficult-to-treat diseases, like muscular dystrophy.

We will now apply this same disruptive RNA technology to develop a novel treatment for chronic kidney disease.


GO ID:
GO Title:
NHMRC Development Grants 2022 for funding in 2023
Internal Reference ID:
2022/GNT2022635
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
Monash University
Recipient ABN:
12 377 614 012

Grant Recipient Location

Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA

Contact Details

NHMRC Research Help Centre

:
1800500393

: